Is HLF a good stock to buy right now?

Based on our 6-factor quantitative model, HERBALIFE LTD. (HLF) receives a "Hold" rating with a composite score of 52.8/100. It is ranked #1,563 out of 4,446 stocks. Key factor scores: Quality 50/100, Value 78/100, Momentum 68/100. The timing signal is "Bearish". This is quantitative analysis only — not investment advice.

What is the stock rating for HLF?

HERBALIFE LTD. (HLF) has a "Hold" rating and 3-star score. The composite score of 52.8 ranks it #1,563 among 4,446 U.S. stocks. Ratings are updated weekly using academically-proven factor models.

What sector is HLF in?

HERBALIFE LTD. operates in the Consumer Staples sector (Wholesale industry) with a market cap of $1.49 billion. It is classified as a small-cap stock.

Does HLF pay a dividend?

HLF does not currently pay a regular dividend. The company may be reinvesting profits for growth.

What is HLF's P/E ratio?

HLF has a trailing P/E ratio of 7.58x. The Consumer Staples sector average is 33.1x. This below-average P/E may indicate the stock is undervalued.

How profitable is HLF?

HLF's quality factor score is 50/100. Gross margin: 78.1%. ROE: -32.4% vs sector average 7.7%. High margins suggest pricing power and competitive moats.

How is HLF valued compared to peers?

HLF's value factor score is 78/100 (higher = cheaper). Key multiples: P/E 7.6x, EV/EBITDA 5.4x. The stock appears attractively valued versus peers.

What is HLF's debt level?

HLF's debt-to-equity ratio is -333%. Sector average: 72%. Low leverage suggests conservative financial management.

HLF has a beta of 0.32, meaning it is less volatile than the market. Stability score: 48/100.

Does HLF have high short interest?

HLF's short interest factor score is 10/100 (higher = less short selling). Elevated short interest may indicate bearish sentiment or short squeeze potential.

HLF Stock Analysis: Top Small-Cap Hold (Score 52.8/100) | Blank Capital Research

Data Series	1D	5D	1M	YTD	1Y	3Y	5Y	10Y
HLF	+0.40%	+9.65%

Metric	HLF	Benchmark
P/E Ratio	7.6x	-77%
EV/EBITDA	5.4x	-22%
Price / Book	-2.5x

Stock Entity	Score▼	Quality	Value	Momentum	P/E Ratio	ROE	Gross Margin	Net Margin	Rev Growth	D/E Ratio	Market Cap	Compare
ITRN Ituran Location & Control Ltd.	60	48	82	70	19.6x	122.1%	47.8%	16.8%	-	0.0x	$1.0B	VS
SENEA Seneca Foods Corp	55	49	59	69	10.3x	14.4%	14.3%	6.7%	70.9%	39.0x	$1.1B	VS
JBSS SANFILIPPO JOHN B & SON INC	54	50	57	61	12.8x	20.2%	19.3%	6.3%	14.0%	11.0x	$965M	VS
ARW ARROW ELECTRONICS, INC.	53	50	73	63	15.8x	7.2%	11.2%	1.6%	11.9%	337.0x	$7.5B	VS
SFD SMITHFIELD FOODS INC	53	50	72	57	13.8x	11.9%	19.9%	7.5%	7.3%	29.0x	$11.3B	VS
BG Bunge Global SA	53	50	54	69	24.9x	5.7%	5.4%	1.8%	67.3%	59.0x	$24.8B	VS
DAR DARLING INGREDIENTS INC.	53	50	55	71	142.7x	1.5%	24.1%	1.2%	13.3%	114.0x	$9.9B	VS
HLF HERBALIFE LTD.	53	50	78	68	7.6x	-32.4%	78.1%	3.8%	-0.6%	-333.0x	$1.5B
ADM Archer-Daniels-Midland Co	52	50	52	64	54.6x	2.8%	6.4%	0.8%	-8.4%	33.0x	$34.9B	VS
CTVA Corteva, Inc.	52	49	51	60	50.6x	4.7%	42.9%	0.2%	-57.2%	76.0x	$56.3B	VS
MO ALTRIA GROUP, INC.	51	50	67	51	13.6x	-	62.1%	33.8%	-2.2%	-990.0x	$109.5B	VS

Key Ratio	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Gross Margin %	0.8%	0.8%	0.8%	0.8%	0.8%	0.8%	0.8%	0.8%	0.8%	0.8%	0.8%
Operating Margin %	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%
EBITDA Margin %	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.2%	0.2%	0.1%
Net Margin %	0.0%	0.0%	0.1%	0.0%	0.1%	0.1%	0.1%	0.1%	0.1%	0.0%	0.1%
FCF Margin %	-	-	3.3%	-	-	-	9.3%	7.2%	11.5%	11.2%	5.0%
ROE %	-37.3%	-44.7%	-31.7%	-13.4%	-25.4%	-32.1%	-43.5%	-79.7%	-41.0%	-63.9%	1.3%
ROA %	0.1%	0.1%	0.1%	0.1%	0.1%	0.2%	0.1%	0.1%	0.1%	0.1%	0.1%
ROIC %	0.3%	25.6%	29.2%	18.7%	30.2%	42.3%	96.0%	78.2%	101.5%	74.5%	45.2%

Key Ratio

TTM

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

Gross Margin %

0.8%

Operating Margin %

0.1%

EBITDA Margin %

0.1%

0.2%

0.1%

Net Margin %

0.0%

0.1%

0.0%

0.1%

0.0%

0.1%

FCF Margin %

3.3%

9.3%

7.2%

11.5%

11.2%

5.0%

ROE %

-37.3%

-44.7%

-31.7%

-13.4%

-25.4%

-32.1%

-43.5%

-79.7%

-41.0%

-63.9%

1.3%

ROA %

0.1%

0.2%

0.1%

ROIC %

0.3%

25.6%

29.2%

18.7%

30.2%

42.3%

96.0%

78.2%

101.5%

74.5%

45.2%

Line Item	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
	$5.0B	$5.0B	$5.0B	$5.1B	$5.2B	$5.8B	$5.5B	$4.9B	$4.9B	$4.4B	$4.5B	$4.5B
	—	$1.1B	—	$1.2B	$1.2B	$1.2B	—	—	—	—	—	—
	$3.9B	$3.9B	$3.9B	$3.9B	$4.0B	$4.6B	$4.4B	$3.9B	$4.0B	$3.6B	$3.6B	$3.6B
Gross Margin	78.1%	77.9%	77.9%	76.5%	77.5%	78.6%	79.2%	80.4%	81.2%	80.8%	81.0%	80.8%
	—	—	—	$1.9B	$1.8B	$2.0B	—	—	—	—	—	—
Depreciation	—	$121M	$135M	$113M	$115M	$108M	$127M	$141M	$164M	$160M	$154M	$154M
Total Operating Expenses	—	$3.4B	—	$3.5B	$3.5B	$3.8B	—	—	—	—	—	—
	$508M	$481M	$386M	$356M	$545M	$734M	$641M	$568M	$683M	$617M	$458M	$584M
EBIT	$508M	$481M	$386M	$356M	$545M	$734M	$641M	$568M	$683M	$617M	$458M	$584M
EBITDA	$631M	$602M	$510M	$470M	$661M	$842M	$768M	$694M	$790M	$778M	$612M	$736M
Operating Margin	10.2%	9.6%	7.7%	7.0%	10.5%	12.7%	11.6%	11.7%	14.0%	13.9%	10.2%	13.1%
EBITDA Margin	12.6%	12.0%	10.2%	9.3%	12.7%	14.5%	13.9%	14.2%	16.1%	17.6%	13.6%	16.5%
	—	$214M	$218M	$166M	$139M	$153M	$133M	$153M	$181M	$161M	$99M	$101M
	—	$275M	—	$203M	$425M	$561M	—	—	—	—	—	—
Income Tax Expense	—	$47M	-$85M	$61M	$104M	$114M	$144M	$140M	$168M	$257M	$105M	$147M
	$190M	$228M	$254M	$142M	$321M	$447M	$373M	$311M	$297M	$214M	$260M	$339M
Net Margin	3.8%	4.5%	5.1%	2.8%	6.2%	7.7%	6.7%	6.4%	6.1%	4.8%	5.8%	7.6%
	$2.22	$2.22	$2.53	$1.44	$3.26	$4.22	$2.83	$2.26	$2.12	$2.70	$3.13	$4.11
Diluted EPS	$2.22	$2.20	$2.53	$1.42	$3.23	$4.13	$2.83	$2.26	$2.12	$2.70	$3.13	$4.11
Weighted Avg Basic	—	103M	—	99M	99M	106M	—	—	—	—	—	—
Weighted Avg Diluted	—	104M	—	100M	100M	108M	—	—	—	—	—	—

Line Item

TTM

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

$5.0B

$5.1B

$5.2B

$5.8B

$5.5B

$4.9B

$4.4B

$4.5B

—

$1.1B

—

$1.2B

—

$3.9B

$4.0B

$4.6B

$4.4B

$3.9B

$4.0B

$3.6B

Gross Margin

78.1%

77.9%

76.5%

77.5%

78.6%

79.2%

80.4%

81.2%

80.8%

81.0%

80.8%

—

$1.9B

$1.8B

$2.0B

—

Depreciation

—

$121M

$135M

$113M

$115M

$108M

$127M

$141M

$164M

$160M

$154M

Total Operating Expenses

—

$3.4B

—

$3.5B

$3.8B

—

$508M

$481M

$386M

$356M

$545M

$734M

$641M

$568M

$683M

$617M

$458M

$584M

EBIT

$508M

$481M

$386M

$356M

$545M

$734M

$641M

$568M

$683M

$617M

$458M

$584M

EBITDA

$631M

$602M

$510M

$470M

$661M

$842M

$768M

$694M

$790M

$778M

$612M

$736M

Operating Margin

10.2%

9.6%

7.7%

7.0%

10.5%

12.7%

11.6%

11.7%

14.0%

13.9%

10.2%

13.1%

EBITDA Margin

12.6%

12.0%

10.2%

9.3%

12.7%

14.5%

13.9%

14.2%

16.1%

17.6%

13.6%

16.5%

—

$214M

$218M

$166M

$139M

$153M

$133M

$153M

$181M

$161M

$99M

$101M

—

$275M

—

$203M

$425M

$561M

—

Income Tax Expense

—

$47M

-$85M

$61M

$104M

$114M

$144M

$140M

$168M

$257M

$105M

$147M

$190M

$228M

$254M

$142M

$321M

$447M

$373M

$311M

$297M

$214M

$260M

$339M

Net Margin

3.8%

4.5%

5.1%

2.8%

6.2%

7.7%

6.7%

6.4%

6.1%

4.8%

5.8%

7.6%

$2.22

$2.53

$1.44

$3.26

$4.22

$2.83

$2.26

$2.12

$2.70

$3.13

$4.11

Diluted EPS

$2.22

$2.20

$2.53

$1.42

$3.23

$4.13

$2.83

$2.26

$2.12

$2.70

$3.13

$4.11

Weighted Avg Basic

—

103M

—

99M

106M

—

Weighted Avg Diluted

—

104M

—

100M

108M

—

HERBALIFE LTD. (HLF) Stock Analysis — April 2026 Rating, Price, and Forecast

Last updated: April 2026

Company Overview — What Does HERBALIFE LTD. Do?

Herbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and rest of Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. It offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products, which comprise functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products, including N-R-G tea and energy drink products. The company also provides literature, promotional, and other materials that comprise start-up kits, sales tools, and educational materials. It offers its products through independent service providers and sales representatives, as well as through company-operated retail platforms. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California. HERBALIFE LTD. (HLF) is classified as a small-cap stock in the Consumer Staples sector, specifically within the Wholesale industry. The company is led by CEO Michael O. Johnson and employs approximately 10,100 people. With a market capitalization of $1.5B, HLF is one of the notable companies in the Consumer Staples sector.

HERBALIFE LTD. (HLF) Stock Rating — Hold (April 2026)

As of April 2026, HERBALIFE LTD. receives a Hold rating with a composite score of 52.8/100 and 3 out of 5 stars from the Blank Capital Research quantitative model.HLF ranks #1,563 out of 4,446 stocks in our coverage universe. Within the Consumer Staples sector, HERBALIFE LTD. ranks #56 of 180 stocks, placing it in the upper half of its Consumer Staples peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

HLF Stock Price and 52-Week Range

HERBALIFE LTD. (HLF) currently trades at $15.20. The stock gained $0.03 (0.2%) in the most recent trading session. The 52-week high for HLF is $20.40, which means the stock is currently trading -25.5% from its annual peak. The 52-week low is $6.20, putting the stock 145.4% above its annual trough. Recent trading volume was 424K shares, suggesting relatively thin trading activity.

Is HLF Overvalued or Undervalued? — Valuation Analysis

HERBALIFE LTD. (HLF) carries a value factor score of 78/100 in the Blank Capital model, suggesting the stock trades at a meaningful discount to its fundamental earning power. The trailing price-to-earnings ratio is 7.58x, compared to the Consumer Staples sector average of 33.11x — a discount of 77%. The price-to-sales ratio is 0.29x, compared to 0.35x for the average Consumer Staples stock. On an enterprise value basis, HLF trades at 5.44x EV/EBITDA, versus 6.93x for the sector.

Based on these multiples, HERBALIFE LTD. appears attractively valued relative to both its sector peers and the broader market. Value-oriented investors may find the current entry point compelling, particularly if the company's fundamental quality metrics also score well.

HERBALIFE LTD. Profitability — ROE, Margins, and Quality Score

HERBALIFE LTD. (HLF) earns a quality factor score of 50/100, indicating solid business quality with consistent operational execution. The return on equity (ROE) is -32.4%, compared to the Consumer Staples sector average of 7.7%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at 6.8% versus the sector average of 3.1%.

On a margin basis, HERBALIFE LTD. reports gross margins of 78.1%, compared to 26.2% for the sector. The operating margin is 10.2% (sector: 2.9%). Net profit margin stands at 3.8%, versus 1.6% for the average Consumer Staples stock. Revenue growth is running at -0.6% on a trailing basis, compared to 3.1% for the sector. The overall profitability profile is adequate, though there may be room for margin expansion.

HLF Debt, Balance Sheet, and Financial Health

HERBALIFE LTD. has a debt-to-equity ratio of -333.0%, compared to the Consumer Staples sector average of 72.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 1.13x, suggesting adequate working capital coverage. Total debt on the balance sheet is $1.99B. Cash and equivalents stand at $306M.

HLF has a beta of 0.32, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for HERBALIFE LTD. is 48/100, reflecting average volatility within the normal range for its sector.

HERBALIFE LTD. Revenue and Earnings History — Quarterly Trend

In TTM 2026, HERBALIFE LTD. reported revenue of $4.99B and earnings per share (EPS) of $2.22. Net income for the quarter was $190M. Gross margin was 78.1%. Operating income came in at $508M.

In FY 2025, HERBALIFE LTD. reported revenue of $5.04B and earnings per share (EPS) of $2.22. Net income for the quarter was $228M. Gross margin was 77.9%. Revenue grew 0.9% year-over-year compared to FY 2024. Operating income came in at $481M.

In Q3 2025, HERBALIFE LTD. reported revenue of $1.27B and earnings per share (EPS) of $0.42. Net income for the quarter was $43M. Gross margin was 77.7%. Revenue grew 2.7% year-over-year compared to Q3 2024. Operating income came in at $126M.

In Q2 2025, HERBALIFE LTD. reported revenue of $1.26B and earnings per share (EPS) of $0.48. Net income for the quarter was $49M. Gross margin was 78.0%. Revenue grew -1.7% year-over-year compared to Q2 2024. Operating income came in at $133M.

Over the past 8 quarters, HERBALIFE LTD. has demonstrated a growth trajectory, with revenue expanding from $1.28B to $4.99B. Investors analyzing HLF stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

HLF Dividend Yield and Income Analysis

HERBALIFE LTD. (HLF) does not currently pay a dividend. This is common among smaller companies in the Wholesale industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Consumer Staples dividend stocks may want to explore other Consumer Staples stocks or use the stock screener to filter by dividend yield.

HLF Momentum and Technical Analysis Profile

HERBALIFE LTD. (HLF) has a momentum factor score of 68/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 34/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 10/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.

HLF vs Competitors — Consumer Staples Sector Ranking and Peer Comparison

Within the Consumer Staples sector, HERBALIFE LTD. (HLF) ranks #56 out of 180 stocks based on the Blank Capital composite score. This places HLF in the upper half of all Consumer Staples stocks in our coverage universe. Key competitors and sector peers include Ituran Location & Control Ltd. (ITRN) with a score of 60.3/100, DARLING INGREDIENTS INC. (DAR) with a score of 52.9/100, Bunge Global SA (BG) with a score of 53.0/100, SANFILIPPO JOHN B & SON INC (JBSS) with a score of 54.1/100, and Archer-Daniels-Midland Co (ADM) with a score of 52.2/100.

Comparing HLF against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full HLF vs S&P 500 (SPY) comparison to assess how HERBALIFE LTD. stacks up against the broader market across all factor dimensions.

HLF Next Earnings Date

No upcoming earnings date has been announced for HERBALIFE LTD. (HLF) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy HLF? — Investment Thesis Summary

HERBALIFE LTD. presents a balanced picture with arguments on both sides. The value score of 78/100 suggests attractive pricing relative to fundamentals. Price momentum is positive at 68/100, suggesting the trend favors buyers.

In summary, HERBALIFE LTD. (HLF) earns a Hold rating with a composite score of 52.8/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on HLF stock.

Related Resources for HLF Investors

Explore more research and tools: HLF vs S&P 500 comparison, top Consumer Staples stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare HLF head-to-head with peers: HLF vs ITRN, HLF vs DAR, HLF vs BG.

Business quality

Valuation edge

Market alpha

Unlock Investment Thesis

Unlock Performance & Technicals

Unlock Valuation Tools

Institutional peer matrix

Dispersion: efficiency vs. valuation

Lateral intelligence network

Unlock Financial Statements

Unlock Ownership & Management

Intelligence Feed

Herbalife acquires personalized nutrition firm Bioniq in $150 million deal

Herbalife Acquires Bioniq Assets Worth 55 Million US Dollars, Strengthening Personal Nutrition Business

Herbalife to acquire Bioniq to expand personalised nutrition capabilities

Herbalife to acquire Bioniq personalized supplement assets for $55M

ZAWYA-PRESSR: Bioniq announces planned acquisition by Herbalife

Unlock Earnings Transcripts

Institutional Intelligence FAQ

Related Research & Tools

Related Consumer Staples Stocks

HERBALIFE LTD. (HLF) Stock Analysis — April 2026 Rating, Price, and Forecast

Company Overview — What Does HERBALIFE LTD. Do?

HERBALIFE LTD. (HLF) Stock Rating — Hold (April 2026)

HLF Stock Price and 52-Week Range

Is HLF Overvalued or Undervalued? — Valuation Analysis

HERBALIFE LTD. Profitability — ROE, Margins, and Quality Score

HLF Debt, Balance Sheet, and Financial Health

HERBALIFE LTD. Revenue and Earnings History — Quarterly Trend

HLF Dividend Yield and Income Analysis

HLF Momentum and Technical Analysis Profile

HLF vs Competitors — Consumer Staples Sector Ranking and Peer Comparison

HLF Next Earnings Date

Should You Buy HLF? — Investment Thesis Summary

Related Resources for HLF Investors

Comments

Institutional Benchmarks

Related research

Get alerted on rating changes

Intelligence Feed

Herbalife acquires personalized nutrition firm Bioniq in $150 million deal

Herbalife Acquires Bioniq Assets Worth 55 Million US Dollars, Strengthening Personal Nutrition Business

Herbalife to acquire Bioniq to expand personalised nutrition capabilities

Herbalife to acquire Bioniq personalized supplement assets for $55M

ZAWYA-PRESSR: Bioniq announces planned acquisition by Herbalife